EV/EBITDA
-16.81
+0.20+1.18%
6 min ago
Summary
- As of February 7, 2025, ESPR EV/EBITDA is -16.81, with a rise of +0.20 (+1.18%) during the most recent trading day.
- Over the past year, ESPR EV/EBITDA has dropped by -12.43 (-283.79%).
- ESPR EV/EBITDA is now -1324.58% below its all-time high of -1.18.
Performance
ESPR EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ESPR EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +1.2% | -1.2% | -1.6% |
| 1 m1 month | +11.8% | -11.8% | -15.3% |
| 3 m3 months | +9.6% | -9.6% | -12.4% |
| 6 m6 months | -47.7% | +4.8% | -6.2% |
| ytdytd | +13.1% | -13.1% | -16.8% |
| 1 y1 year | -283.8% | -26.3% | -30.9% |
| 5 y5 years | +2.8% | -68.4% | -97.0% |
ESPR EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -1.3% | -20.22 | +16.9% | |
| 3 m | 3-month | -16.60 | -1.3% | -30.74 | +45.3% |
| 6 m | 6-month | -9.78 | -71.9% | -30.74 | +45.3% |
| 1 y | 1-year | -3.75 | -348.3% | -30.74 | +45.3% |
| 3 y | 3-year | -1.18 | -1324.6% | -30.74 | +45.3% |
| 5 y | 5-year | -1.18 | -1324.6% | -30.74 | +45.3% |
| alltime | all time | -1.18 | -1324.6% | -61.85 | +72.8% |
Esperion Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -16.81(-13.1%) |
| 2024 | -19.34(+437.2%) |
| 2023 | -3.60(+3.7%) |
| 2022 | -3.47(+116.9%) |
| 2021 | -1.60(-65.3%) |
| 2020 | -4.61(-72.3%) |
| Date | Value |
|---|---|
| 2019 | -16.63(+182.3%) |
| 2018 | -5.89(-42.3%) |
| 2017 | -10.20(+207.2%) |
| 2016 | -3.32(-62.0%) |
| 2015 | -8.73(-57.7%) |
| 2014 | -20.66(+235.9%) |
| 2013 | -6.15 |
FAQ
- What is Esperion Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Esperion Therapeutics?
- What is ESPR EV/EBITDA year-to-date change?
- What is Esperion Therapeutics EV/EBITDA year-on-year change?
What is Esperion Therapeutics EV/EBITDA?
The current EV/EBITDA of ESPR is -16.81
What is the all time high EV/EBITDA for Esperion Therapeutics?
Esperion Therapeutics all-time high EV/EBITDA is -1.18
What is ESPR EV/EBITDA year-to-date change?
Esperion Therapeutics EV/EBITDA has changed by +2.53 (+13.08%) since the beginning of the year
What is Esperion Therapeutics EV/EBITDA year-on-year change?
Over the past year, ESPR EV/EBITDA has changed by -12.43 (-283.79%)